In Search of Selective 11β-HSD 1 Inhibitors without Nephrotoxicity
An Approach to Resolve the Metabolic Syndrome by Virtual Based Screening
978-3-659-79001-0
365979001X
56
2015-10-20
39.90 €
eng
https://images.our-assets.com/cover/230x230/9783659790010.jpg
https://images.our-assets.com/fullcover/230x230/9783659790010.jpg
https://images.our-assets.com/cover/2000x/9783659790010.jpg
https://images.our-assets.com/fullcover/2000x/9783659790010.jpg
Over expression of 11β-HSD 1 in key metabolic tissues is related to the development of type 2 diabetes, obesity, hypertension and metabolic syndrome. Nephrotoxicity of corosolic acid (selective inhibitor of 11β-HSD 1) is recently reported, which is one of the major drawback. Therefore, it is of great interest to find out the selective 11β-HSD 1 inhibitors without nephrotoxicity. Using crystal structures of 11β-HSD 1 in complex with inhibitors as a source of structural information, a combined structure-based virtual screening approach followed by PASS toxicity prediction, Lipinski’s rule and ADME prediction implemented to find out the potent and selective 11 β-HSD 1 analog of corosolic acid without nephrotoxicity.
https://morebooks.de/books/tr/published_by/lap-lambert-academic-publishing/47/products
Eczacılık
https://morebooks.de/store/tr/book/in-search-of-selective-11%CE%B2-hsd-1-inhibitors-without-nephrotoxicity/isbn/978-3-659-79001-0